Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |